journal article·2017-04-03Open access

In vitroeffect of imatinib mesylate loaded on polybutylcyanoacrylate nanoparticles on leukemia cell line K562

Leyla Hasandoost, Azim Akbarzadeh, Hossein Attar, Amir Heydarinasab

Abstract

The study aimed to prepare imatinib mesylate-loaded polybutylcyanoacrylate (PBCA) nanoparticles and evaluate their efficacy on leukemia cell line K562. The formulation was prepared by miniemulsion polymerization technique. Nanoparticles were characterized by dynamic light scattering (DLS), spectrophotometry, Fourier transform infrared spectroscopy (FTIR), dialysis membrane, and 3-(4,5-dimethylthiazol-2-Yl)-2,5-diphenyltetrazolium bromide (MTT) techniques. Nanoscale particles with high encapsulation efficiency (86%) and physical entrapment of drug were observed. In addition, nanoparticles showed suitable drug retention capability and potentiate the cytotoxicity effects of imatinib mesylate. Findings of study suggested PBCA nanoparticles are promising carrier for imatinib mesylate delivery to leukemia cell line K562.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Fiber Optic Sensors · Synthesis and properties of polymers · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran;

Department of Pilot Nanobiotechnology, Pasteur Institute of Iran, Tehran, Iran

References (19)

Show source-provided references
1. 10.1002/wnan.510.1002/wnan.5 ↗
2. 10.1158/1078-0432.CCR-08-131610.1158/1078-0432.CCR-08-1316 ↗
3. 10.2217/17435889.3.4.50710.2217/17435889.3.4.507 ↗
4. 10.1039/C4MD00348A10.1039/C4MD00348A ↗
5. Dikpati A · JAPS. J · 2012 · 2 · 179
6. 10.1007/s13277-014-1996-810.1007/s13277-014-1996-8 ↗
7. 10.1007/s11095-015-1673-710.1007/s11095-015-1673-7 ↗
8. 10.1074/jbc.M80595620010.1074/jbc.M805956200 ↗
9. Honary S · Trop J Pharm Res · 2013 · 12 · 265
10. Hozouri H · Iran J Pharm Res · 2014 · 13 · 143
11. Jayanthi B · J App Pharm Sci · 2011 · 1 · 5010.21065/19257430.50.1 ↗
12. Kimura S · Circulation · 2008 · 118 · S6510.1161/CIRCULATIONAHA.107.740613 ↗
13. Marslin G · Int J Nanomed · 2015 · 10 · 3163
14. Palanisamy K · Dig J Nanomater Biostruct (DJNB) · 2013 · 8 · 607
15. 10.1007/s10529-015-1813-510.1007/s10529-015-1813-5 ↗
16. 10.1166/jnn.2011.424010.1166/jnn.2011.4240 ↗
17. Thampi GR · Indian J Res Pharm Biotechnol · 2014 · 2 · 1082
18. Woo SM · Mol Med Rep · 2015 · 13 · 1091
19. 10.1007/s12274-013-0308-810.1007/s12274-013-0308-8 ↗